Annual Revenue ($)

Pfizer revenue was $41.91 b in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$52.55 b$53.65 b$51.75 b$41.91 b
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$12.91 b$13.47 b$13.3 b$13.12 b$13.26 b$12.68 b$12.03 b$11.8 b$12.13 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Pfizer revenue breakdown by business segment: 19.8% from Upjohn, 76.2% from Biopharma and 4.1% from Other

Pfizer revenue breakdown by geographic segment: 16.8% from Developed Europe, 46.1% from United States, 24.6% from Emerging Markets and 12.5% from Developed Rest of World

FY, 2019FY, 2018FY, 2017
Essential Health$20.22 b$21.12 b
Innovative Health$33.43 b$31.42 b
Consumer Healthcare$2.1 b
Upjohn$10.23 b
Biopharma$39.42 b
FY, 2019FY, 2018FY, 2017
United States$23.85 b$25.33 b$26.03 b
Developed Europe$8.7 b$9.12 b$8.51 b
Developed Rest of World$6.47 b$6.55 b$6.61 b
Emerging Markets$12.73 b$12.65 b$11.4 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu